Ortho Clinical Diagnostics, a global leader of in vitro diagnostics backed by The Carlyle Group, announced Joseph M. Busky has joined the Company as Chief Financial Officer, effective July 7, 2020.
Busky, who previously served as Chief Financial Officer for Vyaire Medical, Inc., has over 30 years of experience in corporate and operational finance for large, global companies across diagnostics, medical devices, telecom, and marketing services.

"Joe has a consistent track record driving value creation and enhancing financial models to yield growth and create long-term value," said Chris Smith, chief executive officer, Ortho Clinical Diagnostics. "As Ortho Clinical Diagnostics continues to innovate to bring fast, accurate, reliable testing solutions to market, Joe's extensive experience and strong financial acumen will ensure the company remains poised to deliver these solutions to patients and health care teams globally."

Joe's extensive experience and strong financial acumen will ensure the company remains poised to deliver these solutions to patients and health care teams globally

Prior to Vyaire, Busky was Chief Financial Officer of FDH Velocitel, an engineering services company in the telecom space. From 2008 – 2015, Busky served as Chief Financial Officer of InnerWorkings, Inc. (Nasdaq: INWK), a global marketing services firm withoperations in 33 countries. Busky previously held corporate and divisional finance roles for a combined 11 years at Siemens Medical Solutions Diagnostics / Dade Behring Holdings, Inc., Bayer Diagnostics and Diagnostic Products Corporation, including serving as Chief Accounting Officer at Dade Behring.

Busky received his Bachelor of Business Administration in Accounting and Master of Business Administration with a finance concentration from Loyola University in Baltimore, MD. He is also a licensed Certified Public Accountant in the state of Maryland.